Clinical Trial Update: Olive Leaf Extracts in the Control of Hypertension [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial is evaluating olive leaf extract for hypertension, spanning Phase 2 and Phase 3, and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Olive Leaf Extract (Olea europaea leaf extract)

Snippet

Sponsor: University of Monastir | Conditions: Hypertension | Phase 2, Phase 3 | Status: RECRUITING